Fig. 2. ZNF281 upregulation predicts worse overall survival (OS) and recurrence-free survival (RFS) in CRC patients. (A) IHC staining for ZNF281 protein in CRC tissues. (B) IHC staining for ZNF281 protein in normal colon tissues. (C) Positive ZNF281 expression predicted poor OS in patients with CRC (P<0.0001). (D) ZNF281-positive expression predicted a poor RFS in patients with CRC (P=0.0003).